L646-0895 Screening compound: N-({1-[(2-fluorophenyl)methyl]piperidin-4-yl}methyl)-5-(5-phenyl-1,2,4-oxadiazol-3-yl)thiophene-2-carboxamide

L646-0895 Screening compound: N-({1-[(2-fluorophenyl)methyl]piperidin-4-yl}methyl)-5-(5-phenyl-1,2,4-oxadiazol-3-yl)thiophene-2-carboxamide
L646-0895 Screening compound: N-({1-[(2-fluorophenyl)methyl]piperidin-4-yl}methyl)-5-(5-phenyl-1,2,4-oxadiazol-3-yl)thiophene-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L646-0895
N-({1-[(2-fluorophenyl)methyl]piperidin-4-yl}methyl)-5-(5-phenyl-1,2,4-oxadiazol-3-yl)thiophene-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L646-0895

Molecular Formula

C26H25FN4O2S (C26 H25 FN4 O2 S)

Compound Name

N-({1-[(2-fluorophenyl)methyl]piperidin-4-yl}methyl)-5-(5-phenyl-1,2,4-oxadiazol-3-yl)thiophene-2-carboxamide

IUPAC name

N-({1-[(2-fluorophenyl)methyl]piperidin-4-yl}methyl)-5-(5-phenyl-124-oxadiazol-3-yl)thiophene-2-carboxamide

SMILES

O=C(c1ccc(-c2noc(-c3ccccc3)n2)s1)NCC1CCN(Cc(cccc2)c2F)CC1

InChI

InChI=1S/C26H25FN4O2S/c27-21-9-5-4-8-20(21)17-31-14-12-18(13-15-31)16-28-25(32)23-11-10-22(34-23)24-29-26(33-30-24)19-6-2-1-3-7-19/h1-11,18H,12-17H2,(H,28,32)

InChI Key

BRSRAMNFZANKOQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27467426

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

476.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.730

Distribution Coefficient, logD

3.941

Water Solubility, LogSw

-5.93

Polar Surface Area

60.808

Acid Dissociation Constant (pKa)

14.58

Base Dissociation Constant (pKb)

9.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

L646-0895 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L646-0895 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L646-0895?
Check Price and Availability of L646-0895, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L646-0895 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L646-0895
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L646-0895
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L646-0895 available by request